Content:
As a renowned manufacturer and supplier in the field of biotechnology, QL biotech guarantees high-quality, reliable, and efficient solutions for diverse health-related concerns. The cornerstone product, the CLO rapid Test Strip, has revolutionized the way healthcare services conduct their diagnostic processes.
QL biotech's portfolio is diverse; it ranges from infectious disease products to cardiac marker detection products, DOA products, and tumor marker products. These products reflect QL biotech's commitment to developing diagnostic tools that address critical health issues dynamically. However, the company's innovation and expertise truly shine in the production of the CLO rapid Test Strip.
The CLO rapid Test Strip provides a quick, semi-quantitative evaluation of C-Reactive Protein (CRP) levels. Measured from whole blood or serum or plasma samples, it can detect CRP concentration between 10 to 80 mg/L. Unlike traditional CRP tests, this product offers nearly immediate results, easing the stress of waiting and enabling healthcare providers to act swiftly depending on the results.
Apart from the C-Reactive Protein detection, QL biotech also takes a lead in manufacturing rapid tests for more severe and timely concerns. This includes the COVID-19 Ag Rapid Test kits, SARS-CoV-2 Antigen Rapid Test Device for saliva, HIV 1/2/O Tri‐line Human Immunodeficiency Virus Rapid Test Device/Strip, and fFN rapid test Device/Strip for vaginal secretion. These products, like the CLO rapid Test Strip, are designed for ease-of-use and accuracy, allowing both professionals and consumers to make informed health decisions promptly.
Continuing its robust growth in the medical diagnostics field, QL biotech is set on further enhancing its product portfolio. One such innovation is the HIV 1&2 Human Immunodeficiency Virus Rapid Test Strip/Device. This equipment is testament to the company's dedication to facilitate fast and accurate HIV screening, thus contributing to the global effort in managing and eventually eradicating this devastating disease.
In conclusion, QL biotech, with its remarkable product line, is contributing significantly to the healthcare industry. Through the development of efficient diagnostic tools like the CLO rapid Test Strip and other rapid testing products, QL biotech has demonstrated its capabilities to stand at the forefront of the biotech industry. The company’s innovative products are destined to shape the future od medical science, diagnostics and possibly, the health of humanity itself.
